MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 290 filers reported holding MIRATI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4 | -100.0% | 105 | -49.0% | 0.00% | – |
| Q3 2022 | $13,000 | -35.0% | 206 | -32.5% | 0.00% | – |
| Q2 2022 | $20,000 | +17.6% | 305 | +44.5% | 0.00% | – |
| Q1 2022 | $17,000 | -39.3% | 211 | +9.9% | 0.00% | – |
| Q4 2021 | $28,000 | +12.0% | 192 | +35.2% | 0.00% | – |
| Q3 2021 | $25,000 | +4.2% | 142 | -4.7% | 0.00% | – |
| Q2 2021 | $24,000 | -57.9% | 149 | -55.5% | 0.00% | – |
| Q1 2021 | $57,000 | -49.6% | 335 | -35.0% | 0.00% | -100.0% |
| Q4 2020 | $113,000 | +91.5% | 515 | +44.7% | 0.00% | 0.0% |
| Q3 2020 | $59,000 | +1080.0% | 356 | +691.1% | 0.00% | – |
| Q2 2020 | $5,000 | -94.4% | 45 | -96.1% | 0.00% | -100.0% |
| Q3 2019 | $90,000 | – | 1,153 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $116,595,216 | 81.37% |
| ORACLE INVESTMENT MANAGEMENT INC | 201,400 | $7,488,052 | 7.25% |
| Paradigm Biocapital Advisors LP | 1,396,779 | $51,932,243 | 4.92% |
| Octagon Capital Advisors LP | 750,000 | $27,885,000 | 4.01% |
| Boxer Capital, LLC | 2,000,000 | $74,360 | 3.65% |
| Artal Group S.A. | 1,537,709 | $57,172 | 3.40% |
| Avoro Capital Advisors LLC | 5,555,555 | $206,555,535 | 3.06% |
| RTW INVESTMENTS, LP | 3,643,114 | $135,450,979 | 2.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 244,000 | $9,071,920 | 2.53% |
| Kynam Capital Management, LP | 499,853 | $18,584,535 | 2.40% |